EVERETT HARRIS & CO /CA/ - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 13 filers reported holding Novozymes A/S in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EVERETT HARRIS & CO /CA/ ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2019$268,000
+16.0%
5,5000.0%0.01%0.0%
Q3 2019$231,000
-9.8%
5,5000.0%0.01%0.0%
Q2 2019$256,000
+1.2%
5,5000.0%0.01%
-14.3%
Q1 2019$253,000
+2.8%
5,5000.0%0.01%0.0%
Q4 2018$246,000
-18.3%
5,5000.0%0.01%
-12.5%
Q3 2018$301,0000.0%5,500
-7.9%
0.01%0.0%
Q2 2018$301,000
-2.9%
5,974
+0.8%
0.01%
-11.1%
Q1 2018$310,000
-21.5%
5,925
-14.4%
0.01%
-18.2%
Q4 2017$395,000
+11.0%
6,9250.0%0.01%0.0%
Q3 2017$356,000
+17.5%
6,9250.0%0.01%
+22.2%
Q2 2017$303,000
-30.0%
6,925
-36.6%
0.01%
-35.7%
Q1 2017$433,000
+14.9%
10,9250.0%0.01%
+7.7%
Q4 2016$377,000
-36.7%
10,925
-18.6%
0.01%
-38.1%
Q3 2016$596,000
-7.6%
13,4250.0%0.02%
-8.7%
Q2 2016$645,000
+7.1%
13,4250.0%0.02%
+4.5%
Q1 2016$602,000
-6.1%
13,4250.0%0.02%0.0%
Q4 2015$641,000
+10.1%
13,4250.0%0.02%
+4.8%
Q3 2015$582,000
-8.8%
13,4250.0%0.02%
-4.5%
Q2 2015$638,000
+4.1%
13,4250.0%0.02%
+4.8%
Q1 2015$613,000
+17.0%
13,425
+8.0%
0.02%
+16.7%
Q4 2014$524,000
-2.4%
12,4250.0%0.02%
-5.3%
Q3 2014$537,000
-10.5%
12,425
+4.2%
0.02%
-13.6%
Q2 2014$600,000
+14.5%
11,9250.0%0.02%
+15.8%
Q1 2014$524,000
+4.0%
11,9250.0%0.02%0.0%
Q4 2013$504,000
+20.3%
11,925
+9.2%
0.02%
+11.8%
Q3 2013$419,000
+19.4%
10,9250.0%0.02%
+13.3%
Q2 2013$351,00010,9250.02%
Other shareholders
Novozymes A/S shareholders Q1 2017
NameSharesValueWeighting ↓
ZEVIN ASSET MANAGEMENT LLC 50,864$4,228,0000.76%
Moloney Securities Asset Management, LLC 5,650$464,0000.08%
Boston Common Asset Management, LLC 10,371$852,0000.03%
ST GERMAIN D J CO INC 5,000$416,0000.02%
Private Capital Group, LLC 324$27,0000.01%
MAR VISTA INVESTMENT PARTNERS LLC 723$59,0000.00%
CAPTRUST FINANCIAL ADVISORS 2,379$198,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,597$295,0000.00%
View complete list of Novozymes A/S shareholders